Changes in public preferences for technologically enhanced surveillance following the COVID-19 pandemic: a discrete choice experiment.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
18 11 2020
Historique:
entrez: 19 11 2020
pubmed: 20 11 2020
medline: 15 12 2020
Statut: epublish

Résumé

As governments attempt to navigate a path out of COVID-19 restrictions, robust evidence is essential to inform requirements for public acceptance of technologically enhanced communicable disease surveillance systems. We examined the value of core surveillance system attributes to the Australian public, before and during the early stages of the current pandemic. A discrete choice experiment was conducted in Australia with a representative group of respondents, before and after the WHO declared COVID-19 a Public Health Emergency of International Concern. We identified and investigated the relative importance of seven attributes associated with technologically enhanced disease surveillance: respect for personal autonomy; privacy/confidentiality; data certainty/confidence; data security; infectious disease mortality prevention; infectious disease morbidity prevention; and attribution of (causal) responsibility. Specifically, we explored how the onset of the COVID-19 outbreak influenced participant responses. 2008 Australians (general public) completed the experiment: 793 before COVID-19 outbreak onset (mean age 45.9 years, 50.2% male) and 1215 after onset (mean age 47.2 years, 49% male). All seven attributes significantly influenced respondents' preferences for communicable disease surveillance systems. After onset, participants demonstrated greater preference for a surveillance system that could prevent a higher number of illnesses and deaths, and were less concerned about their personal autonomy. However, they also increased their preference for a system with high data security. Public acceptance of technology-based communicable disease surveillance is situation dependent. During an epidemic, there is likely to be greater tolerance of technologically enhanced disease surveillance systems that result in restrictions on personal activity if such systems can prevent high morbidity and mortality. However, this acceptance of lower personal autonomy comes with an increased requirement to ensure data security. These findings merit further research as the pandemic unfolds and strategies are put in place that enable individuals and societies to live with SARS-CoV-2 endemicity.

Identifiants

pubmed: 33208337
pii: bmjopen-2020-041592
doi: 10.1136/bmjopen-2020-041592
pmc: PMC7677347
doi:

Types de publication

Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e041592

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

Value Health. 2016 Jun;19(4):300-15
pubmed: 27325321
Asian Bioeth Rev. 2019;11(2):173-187
pubmed: 32218872
PLoS Comput Biol. 2015 Feb 09;11(2):e1003904
pubmed: 25664461
Lancet. 2020 Mar 21;395(10228):931-934
pubmed: 32164834
Science. 2020 May 8;368(6491):
pubmed: 32234805
Health Econ. 2012 Feb;21(2):145-72
pubmed: 22223558
JMIR Mhealth Uhealth. 2015 Jan 19;3(1):e8
pubmed: 25599627
BMJ Open. 2016 May 04;6(5):e011397
pubmed: 27147392
BMC Med. 2015 Sep 07;13:214
pubmed: 26404673
Health Res Policy Syst. 2019 Apr 4;17(1):35
pubmed: 30947721
BMC Med Ethics. 2020 Apr 25;21(1):31
pubmed: 32334597
Nature. 2020 May 19;:
pubmed: 32433633
JAMA. 2020 Apr 14;323(14):1341-1342
pubmed: 32125371
Lancet Public Health. 2020 May;5(5):e238-e239
pubmed: 32325013
Med Decis Making. 2014 Jul;34(5):638-54
pubmed: 24713695
BMC Med Ethics. 2016 Nov 10;17(1):73
pubmed: 27832780
Lancet Public Health. 2017 Aug;2(8):e348-e349
pubmed: 29253471
Int J Popul Data Sci. 2019 Feb 12;4(1):586
pubmed: 34095528
Pharmacoeconomics. 2008;26(8):661-77
pubmed: 18620460
Epidemiol Infect. 2019 Jan;147:e101
pubmed: 30869042
BMC Public Health. 2017 Apr 4;17(1):295
pubmed: 28376752
Microbes Infect. 2020 Mar;22(2):86-91
pubmed: 32088333
Aust N Z J Public Health. 2019 Feb;43(1):33-40
pubmed: 30516306
Lancet. 2020 Mar 14;395(10227):848-850
pubmed: 32151326

Auteurs

Chris Degeling (C)

Australian Centre for Health Engagement, Evidence and Values, University of Wollongong, Wollongong, New South Wales, Australia degeling@uow.edu.au gang.chen@monash.edu.

Gang Chen (G)

Centre for Health Economics, Monash Business School, Monash University, Caufield East, Victoria, Australia degeling@uow.edu.au gang.chen@monash.edu.

Gwendolyn L Gilbert (GL)

Sydney Health Ethics, Sydney School of Public Health, The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.
Marie Bashir Institute for Emerging Infectious Disease and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia.

Victoria Brookes (V)

School of Animal and Veterinary Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia.

Thi Thai (T)

Centre for Health Economics, Monash Business School, Monash University, Caufield East, Victoria, Australia.

Andrew Wilson (A)

Menzies Centre for Health Policy, The University of Sydney, Sydney, New South Wales, Australia.

Jane Johnson (J)

Marie Bashir Institute for Emerging Infectious Disease and Biosecurity, The University of Sydney, Sydney, New South Wales, Australia.
Department of Philosophy, Macquarie University, Sydney, New South Wales, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH